Differential effects of AT1 receptor and Ca2+ channel blockade on atherosclerosis, inflammatory gene expression, and production of reactive oxygen species

被引:35
作者
Doran, Derek E. [1 ]
Weiss, Daiana [1 ]
Zhang, Yong [1 ]
Griendling, Kathy K. [1 ]
Taylor, W. Robert [1 ]
机构
[1] Emory Univ, Sch Med, Div Cardiol, Atlanta, GA 30322 USA
关键词
atherosclerosis; angiotensin II; angiotensin II receptor antagonists; oxidative stress; vascular biology;
D O I
10.1016/j.atherosclerosis.2006.11.030
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Angiotensin 11 receptor blockade has been shown to inhibit atherosclerosis in several different animal models. We sought to determine if this effect was the result of blood pressure reduction per se or a result of the anti-inflammatory effects of receptor blockade. ApoE-deficient mice were fed a high fat diet and treated with either an angiotensin II receptor antagonist, candesartan (0.5 mg/kg/day, SC) or a calcium channel blocker, amlodipine (7.5 mg/kg/day, mixed with food). Atherosclerotic lesion area, aortic inflammatory gene expression as well as aortic H2O2 and superoxide production were assayed. We found that candesartan but not amlodipine treatment dramatically attenuated the development of atherosclerosis despite a similar reduction in blood pressure. Similarly, candesartan treatment inhibited aortic expression of inflammatory genes and production of reactive oxygen species, effects not seen with amlodipine. These data demonstrate that angiotensin II receptor blockade inhibits atherosclerosis by reducing vascular oxidative stress and inflammatory gene production independent of blood pressure reduction. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:39 / 47
页数:9
相关论文
共 56 条
[1]  
*ALLHAT OFF COORD, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981
[2]  
Andersson R G, 1994, J Physiol Pharmacol, V45, P13
[3]   Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis [J].
Boring, L ;
Gosling, J ;
Cleary, M ;
Charo, IF .
NATURE, 1998, 394 (6696) :894-897
[4]  
Braunwald E, 2004, NEW ENGL J MED, V351, P2058
[5]   ESSENTIAL HYPERTENSION - RENIN AND ALDOSTERONE, HEART ATTACK AND STROKE [J].
BRUNNER, HR ;
BUHLER, FR ;
BARD, RH ;
BAER, L ;
GOODWIN, FT ;
NEWTON, MA ;
KRAKOFF, LR ;
LARAGH, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 1972, 286 (09) :441-+
[6]   Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice [J].
Candido, R ;
Jandeleit-Dahm, KA ;
Cao, ZM ;
Nesteroff, SP ;
Burns, WC ;
Twigg, SM ;
Dilley, RJ ;
Cooper, ME ;
Allen, TJ .
CIRCULATION, 2002, 106 (02) :246-253
[7]   Monocyte chemoattractant protein-1 expression in aortic tissues of hypertensive rats [J].
Capers, Q ;
Alexander, RW ;
Lou, PP ;
De Leon, H ;
Wilcox, JN ;
Ishizaka, N ;
Howard, AB ;
Taylor, WR .
HYPERTENSION, 1997, 30 (06) :1397-1402
[8]  
Capers Q, 1997, CIRC RES, V80, P838
[9]   Molecular dissection of angiotensin II-activated human LOX-1 promoter [J].
Chen, JW ;
Liu, Y ;
Liu, HM ;
Hermonat, PL ;
Mehta, JL .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (05) :1163-1168
[10]   TRANDOLAPRIL INHIBITS ATHEROSCLEROSIS IN THE WATANABE HERITABLE HYPERLIPIDEMIC RABBIT [J].
CHOBANIAN, AV ;
HAUDENSCHILD, CC ;
NICKERSON, C ;
HOPE, S .
HYPERTENSION, 1992, 20 (04) :473-477